Industry Roundup: J&J Trims Splenda, Hearthside Boosts Capacity
This article was originally published in The Tan Sheet
Executive Summary
Splenda in J&J’s past; Hearthside boosts bar capacity; speech supplement refunds; and more news in brief.
You may also be interested in...
Enfamil NeuroPro Ingredient Tests Miss, J&J Doubts Mommy's Bliss Claims
Council of Better Business Bureaus' industry self-regulation arm reviews claims for Mead Johnson's s Enfamil NeuroPro infant formula on challenge by Similac marketer Abbott Nutrition. Recent reviews also include ad claims for children's herbal remedies marketed by Mommy’s Blisson challenged by J&J's consumer business.
Somaderm 'FDA Registered' But Not 'Approved' – Similac-Enfamil Comparison Also Reviewed
Similac marketer Abbott Nutrition supports most but not all ad claims comparing its Human Milk Fortifier to Enfamil's; Council of Better Business Bureaus' investigative arms review claims comparing two baby probiotic drop brands and a protein digesting enzyme ad.
Industry News: Twinlab Into Resveratrol, Hi-Tech Buys LG Brands
Consent decree for Iowa Select; Hi-Tech extends into sports nutrition with LG brands; NBTY adds another Coca-Cola exec to its top management; and more news in brief.